Cushing's syndrome: vizsgálatok itt: Ausztria

1 trial · From EU CTIS (euclinicaltrials.eu), checked 2026. november 13.. Ask the study team whether a trial fits you.

• 2/3. fázisNot yet taking people in Ausztria
  A Multicenter, Phase 2/3, Dose Range Finding Study to Evaluate the Efficacy and Safety of Atumelnant in Adults with ACTH-Dependent Cushing’s Syndrome (ADCS) Including an Open-Label Extension for Long-Term Assessment. (EQUILIBRIUM-ADCS)

  Where

  Graz, Vienna

  Életkor

  18 év and over

  People

  97 worldwide

  Run by

  Crinetics Pharmaceuticals Inc.

  See details and how to join2025-522648-42-01